|4Jun 15, 6:08 PM ET

O'Loughlin Steve 4

4 · Actinium Pharmaceuticals, Inc. · Filed Jun 15, 2018

Insider Transaction Report

Form 4
Period: 2018-06-15
O'Loughlin Steve
Chief Financial Officer
Transactions
  • Purchase

    Common Stock

    2018-06-15$0.50/sh+12,000$6,00025,500 total

Documents

1 file
  • 4
    f4061518oloughlin_actinium.xmlPrimary

    OWNERSHIP DOCUMENT